Abstract:Background: Systemic autoinflammatory diseases (SAID) are rare inherited disorders involving genes regulating innate immune signaling and are characterized by periodic or chronic multi-systemic inflammation. Objective: To describe spectrum of clinical, immunological, molecular features, and outcomes of patients with SAID in India. Methods: Request to share data was sent to multiple centers in India that are involved in care and management of patients with Inborn Errors of Immunity. Six centers provided requisite data that were compiled and analyzed. Results: Data on 107 patients with SAID were collated—of these, 29 patients were excluded due to unavailability of complete information. Twelve patients (15%) had type 1 interferonopathies, 21 (26%) had diseases affecting inflammasomes, 30 patients (41%) had non-inflammasome related conditions and 1five patients (19%) had Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA). Type1 interferonopathies identified in the cohort included patients with Deficiency of Adenosine Deaminase 2 ( DADA2) (six patients; five families); STING-associated vasculopathy infantile-onset (SAVI) (three patients, one family); Spondyloenchondro-dysplasia with Immune Dysregulation (SPENCD) (two patients). Diseases affecting inflammasomes include Mevalonate Kinase Deficiency (eight patients); Cryopyrin-Associated Periodic Syndromes (CAPS) (seven patients); NLR Family, Pyrin domain-containing 12 ( NLRP12) (two patients); Familial Mediterranean fever (FMF) (two patients); Autoinflammation and PLCG 2 -associated antibody deficiency and immune dysregulation (APLAID) (two patients). TNF receptor-associated periodic syndrome (TRAPS) (three patients); A20 haploinsufficiency (four patients); Deficiency of Interleukin 1 Receptor Antagonist (DIRA) (two patients) were categorized as non-inflammasome related conditions. There were significant delays in diagnosis Corticosteroids and other immunosuppressive agents were used for treatment as anti-IL-1 drugs and other biological agents were and still are not available in India. Eight (16.3%) patients had so far succumbed to their illness. Conclusions: This is the first nationwide cohort of patients with SAID from India. Clinical manifestations were diverse. Overlapping of clinical features with other relatively common rheumatological disorders often resulted in delays in diagnosis. More nationwide efforts are needed to enhance awareness of SAID among health care professionals and there is an urgent need to make targeted immunotherapies universally available.

How to Build a Fire: the Genetics of Autoinflammatory Diseases.

Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review

Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approaches

Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease

Autoinflammatory Diseases: A Review

Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers

Overview of Systemic Autoinflammatory Diseases

IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting

Emerging concepts and treatments in autoinflammatory interferonopathies and monogenic systemic lupus erythematosus

Autoinflammation: translating mechanism to therapy

Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases

Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease

Autoinflammation: Past, Present, and Future

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

Autoinflammatory Contributors to Cytokine Storm

Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review

Single-Center Overview of Pediatric Monogenic Autoinflammatory Diseases in the Past Decade: A Summary and Beyond

How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases

Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience

Phenotype variability of autoinflammatory disorders in the pediatric patient: A pictorial overview

New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis